Related Experiment Videos
Pyruvate dehydrogenase E3 binding protein (protein X) deficiency
R M Brown1, R A Head, A A M Morris
1Genetics Unit, Department of Biochemistry, University of Oxford, Oxford, UK.
Developmental Medicine and Child Neurology
|August 15, 2006
Summary
Pyruvate dehydrogenase (PDH) deficiency, primarily caused by PDHA1 mutations, can also result from PDX1 mutations. Defects in the E3 binding protein (E3BP) gene (PDX1) are more common than previously thought and cause less severe neurological dysfunction.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Neurology
Background:
- Pyruvate dehydrogenase (PDH) deficiency is a significant cause of infant and childhood neurological dysfunction and lactic acidosis.
- Most cases (>80%) stem from mutations in the PDHA1 gene, encoding the E1alpha subunit.
- Defects in dihydrolipoamide dehydrogenase (E3) and E3 binding protein (E3BP) are other known contributors to PDH deficiency.
Observation:
- Previously considered rare, mutations in PDX1, the gene for E3BP, are now recognized as relatively common.
- Six new patients (four males, two females; age range 15 months to 6 years) with PDX1 mutations were analyzed.
- All identified E3BP deficiency patients have mutations preventing protein synthesis.
Findings:
- Clinical, biochemical, and genetic data from new and existing PDX1 mutation patients were compared.
- Patients with E3BP deficiency generally present with less severe neurological impairment compared to PDHA1 mutation patients.
- Despite severity differences, clinical and neuroradiological features show considerable overlap between E3BP and PDHA1 deficiencies.
Implications:
- This study highlights that PDX1 mutations are a more frequent cause of PDH deficiency than previously assumed.
- Understanding the genetic basis of PDH deficiency, including E3BP defects, aids in diagnosis and management.
- Further research into the spectrum of PDH deficiency caused by E3BP mutations is warranted to refine prognostic indicators.